This article is more than 5 years old. Information may no longer be current.

A new look for a new era in glaucoma

Thomas W. Samuelson, MD, becomes Ocular Surgery News Glaucoma Section Editor.

Issue: January 1, 2006

ByThomas W. Samuelson, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

I am extremely pleased to be a part of the newly revised Glaucoma Section of Ocular Surgery News. I am especially pleased to introduce the “Glaucoma Home Page,” which will serve as the gateway to relevant glaucoma-related news, commentary and information appearing within the Glaucoma Section of each issue of OSN. We have recruited a superb glaucoma editorial board to provide high-level insight into the advances in the field.

Given the prevalence of glaucoma and the rate of developments in anterior segment surgery, our board will attempt to provide context pertaining to advances in cataract and refractive surgery and high-technology IOL implants that are relevant to patients with glaucoma.

New quarterly features

The new board has an ambitious agenda. Several quarterly features are planned by our Section Members. Beginning in February, Douglas J. Rhee, MD, of Boston, will provide a quarterly column reviewing advances in glaucoma basic research and the implications for clinical practice. James D. Brandt, MD, will keep us abreast of technological advances in glaucoma diagnosis, as well as the implications of ongoing clinical trials that frame our treatment paradigms.

George L. Spaeth, MD, of Wills Eye Hospital, will provide commentary based on his unparalleled experience in the clinical trenches, the only setting where we gain the insight necessary to even partially understand the human toll that the glaucomas inflict on our patients. Nathan Congdon, MD, MPH, of the Wilmer Eye Institute, will author a column pertaining to epidemiology and the global implications of glaucoma and related disorders. Dr. Congdon’s column will begin in April, and the first installment will describe the experience of Richard P. Wilson, MD. We also look forward to contributions from our other Section Members, who include Ike K. Ahmed, MD; Alan S. Crandall, MD; Steven J. Gedde, MD; Marlene R. Moster, MD; Alan L. Robin, MD; Bradford J. Shingleton, MD; and Robert N. Weinreb, MD. Members of the editorial board will also periodically participate in roundtable discussions.

Finally, I will contribute a quarterly column entitled “Glaucoma and the Anterior Segment,” which will attempt to bridge the gap between glaucoma and the rest of anterior segment surgery. More than ever it seems that matters relevant to glaucoma management have branches that extend to nearly all aspects of anterior segment surgery.

Pipeline, Breaking News

In each issue, we will highlight those drugs and devices that have recently gained regulatory approval or are awaiting approval. These will be found in our “Glaucoma Pipeline.” Also, we will gather recent glaucoma features from www.OSNSuperSite.com, in “Glaucoma Breaking News.”

Global glaucoma surgery

In this inaugural edition of the Glaucoma Home Page, Richard A. Lewis, MD, of Sacramento, Calif., offers his compelling first-hand account of a recent Project Orbis trip to Libya. With this story and the other features to follow, our hope is to raise awareness of the need for increased resources in the global mission to reduce blindness from glaucoma and related conditions.

To this end, in the future, the Glaucoma Home Page will provide a listing of opportunities to participate in mission glaucoma surgery and, perhaps more important, the education of our ophthalmic colleagues practicing in countries less fortunate than ours. Perhaps the experience of our guest writers and column editor Dr. Congdon will inspire others to get involved in this imposing yet tremendously rewarding objective. It is appropriate that OSN involve itself in this mission.

For Your Information:

• Thomas W. Samuelson, MD, OSN Glaucoma Surgery Section Editor, can be reached at Minnesota Eye Consultants, 710 E. 24th St., Suite 106, Minneapolis, MN 55404; 612-813-3628; fax: 612-813-3656; e-mail: twsamuelson@mneye.com.